<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-IDN-T-AISYIYA</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Towards an Indonesia free of Tuberculosis</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Indonesia - Tuberculosis - Central Board of &#x2018;Aisyiyah - AISYIYA.  This program has the following goals: To reduce TB related morbidity and mortality in thirty four provinces of Indonesia, with strong contribution of health and community systems.  To halt and reduce drug resistant TB incidence among new TB cases at community.  To reduce TB/HIV related mortality. The objectives of this program are: To  achieve universal access to prevention of TB infection and care, support, and treatment of TB for key affected populations at higher risk, people living with HIV and  general population through TB program leaderships strengthening at national and sub-national level.  Increase detection and notification of all forms  of TB From 129/100,000 pop in 2015 to 240/100,000 pop by 2020.  Ensure treatment success of 90% for drug-sensitive TB treatment in NTP and non NTP providers by 2020..  Ensure universal access to diagnosis and treatment for drug-resistant TB by 2020 (55% of estimated MDR cases are diagnosed &amp; treated by 2020 and 80% by 2025)</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Country Coordinating Mechanism Indonesia</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Country Coordinating Mechanism Indonesia</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="IDN-T-AISYIYA" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="ff7ed07b-94ca-407c-8af8-6cfd2ee2bef6" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-01-01" type="1"></activity-date>
  <activity-date iso-date="2014-01-01" type="2"></activity-date>
  <activity-date iso-date="2020-12-31" type="3"></activity-date>
  <activity-date iso-date="2020-12-31" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Tomas HATEM</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>tomas.hatem@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Tomas HATEM</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>tomas.hatem@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ID" percentage="100">
   <narrative xml:lang="EN">Indonesia</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="377e77b0-66ac-4c7f-ac89-df8b35d557f5">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2014-06-18"></transaction-date>
   <value currency="USD" value-date="2014-06-18">4011514</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="1dc0de99-c5ae-4568-9bf0-fefbdd375da9">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-06-26"></transaction-date>
   <value currency="USD" value-date="2015-06-26">-1014797</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0313ea68-bef9-4a9a-9933-37cb9a58a9ad">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-06-26"></transaction-date>
   <value currency="USD" value-date="2015-06-26">2399202</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="fee4fdca-9245-4a8d-b83e-aa4358c30079">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-02-10"></transaction-date>
   <value currency="USD" value-date="2016-02-10">11375606</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0bf16abb-34d6-4f4f-9bca-6ed5f9ad34ea">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-06-21"></transaction-date>
   <value currency="USD" value-date="2017-06-21">-3668114</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="200c69ad-1ccc-4735-bc30-33a4cc2331e7">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-06-21"></transaction-date>
   <value currency="USD" value-date="2017-06-21">7535104</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4291a66d-a675-4abf-8924-b956c00bd331">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-02-01"></transaction-date>
   <value currency="USD" value-date="2018-02-01">6966976</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3e663d2e-261e-4959-a4f5-1a894ea3d295">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-12-18"></transaction-date>
   <value currency="USD" value-date="2018-12-18">-1979245</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a97cd726-e994-44c7-8ac0-f7c5c6ca9ee0">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-15"></transaction-date>
   <value currency="USD" value-date="2019-01-15">-746.15</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="956cb385-e759-4c70-a84a-989dba3a8be3">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-30"></transaction-date>
   <value currency="USD" value-date="2019-01-30">-158.85</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a87bb3d4-0748-441f-acce-b119a0ba76a1">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-05-17"></transaction-date>
   <value currency="USD" value-date="2019-05-17">-1350068</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="253c8c6f-f983-4c3b-af7e-4d8b576af6a1">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-05-17"></transaction-date>
   <value currency="USD" value-date="2019-05-17">3396006</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0ec39488-8d37-45ed-94a9-46f42f566c28">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-02-05"></transaction-date>
   <value currency="USD" value-date="2020-02-05">-247668</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4e2b74f8-7bce-4ad8-924d-f4669fcf3aba">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-02-05"></transaction-date>
   <value currency="USD" value-date="2020-02-05">1992219.94</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a30b0adb-d96c-4da3-b7df-b9ba570fe3a6">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-06-11"></transaction-date>
   <value currency="USD" value-date="2020-06-11">2442290</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3125d409-1c22-495e-adb2-698a1343a526">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-04-08"></transaction-date>
   <value currency="USD" value-date="2021-04-08">341955</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="54f65fe5-1197-4e2b-b6bf-a574fc9279cb">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-06-19"></transaction-date>
   <value currency="USD" value-date="2014-06-19">1905934</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3ae854b8-8b6f-4faa-95fc-878fbc1b4fb3">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-12-16"></transaction-date>
   <value currency="USD" value-date="2014-12-16">1090783</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="eb91f5ec-61ae-49a0-8714-bd36bedf7e24">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-06-29"></transaction-date>
   <value currency="USD" value-date="2015-06-29">1662400</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="162d57e8-477c-4e8d-97b2-f0f4d121263b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-11-03"></transaction-date>
   <value currency="USD" value-date="2015-11-03">736802</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e5af0e4c-52a9-4f61-95da-b585bf3fbef3">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-02-12"></transaction-date>
   <value currency="USD" value-date="2016-02-12">1506004</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3f8c2075-14e6-4301-8bef-30c2123f8700">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-05-03"></transaction-date>
   <value currency="USD" value-date="2016-05-03">1826336</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="08bef9f1-cbee-432f-8071-55aa6e3d22e1">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-08-16"></transaction-date>
   <value currency="USD" value-date="2016-08-16">845975</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="59789655-63b8-493d-8e7b-5c9aedc4c88b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-11-10"></transaction-date>
   <value currency="USD" value-date="2016-11-10">1104897</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="70f74103-77d0-4f69-a636-58ccc23c440e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-02-09"></transaction-date>
   <value currency="USD" value-date="2017-02-09">2424280</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="5dfb93cf-772c-4d38-a60a-1929b1795285">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-06-22"></transaction-date>
   <value currency="USD" value-date="2017-06-22">2699109</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9201e378-267a-4b1c-aebf-8ae54f0510e8">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-13"></transaction-date>
   <value currency="USD" value-date="2017-10-13">1000815</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6bf3aa65-66d1-434e-a9fc-afdcc1d1d7cb">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-31"></transaction-date>
   <value currency="USD" value-date="2017-10-31">1855935</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="f67c3ea4-0d9c-4879-8ba6-b61c666ad1ca">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-02"></transaction-date>
   <value currency="USD" value-date="2018-02-02">149771</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7f49ecf0-3e81-4b3e-85f9-5b5daa4242ff">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-03-22"></transaction-date>
   <value currency="USD" value-date="2018-03-22">2486725</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="767c3f26-a955-4e06-adc0-a72bce65a9ac">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-09-20"></transaction-date>
   <value currency="USD" value-date="2018-09-20">523549</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="04d4ee9e-4c78-4e48-a90d-b14c44e19d9b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-11-27"></transaction-date>
   <value currency="USD" value-date="2018-11-27">528053</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3313d594-ce5e-4247-bf38-c815ad93ed96">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-01"></transaction-date>
   <value currency="USD" value-date="2019-03-01">1928810</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8493d174-8a10-44fc-90a0-b0a7ec461616">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-05-23"></transaction-date>
   <value currency="USD" value-date="2019-05-23">1339160</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c3fa82f2-1faa-4811-b0c4-068938edf86c">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-02"></transaction-date>
   <value currency="USD" value-date="2019-08-02">870166</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c2e3bf6f-7087-4702-858a-fbb3f71e9705">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-01"></transaction-date>
   <value currency="USD" value-date="2019-11-01">939012</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="db19eb88-09d2-4a6a-959d-1034a57e683d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-06"></transaction-date>
   <value currency="USD" value-date="2020-02-06">1992219.94</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="472fb9ae-7923-4829-80c5-05b7de61676a">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-16"></transaction-date>
   <value currency="USD" value-date="2020-06-16">428141</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0d3d8326-5cf6-4b93-9d3a-be6828171db3">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-05"></transaction-date>
   <value currency="USD" value-date="2020-08-05">644915</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="39e4919e-c26f-4aa4-a75c-f154e8fd3132">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-21"></transaction-date>
   <value currency="USD" value-date="2020-10-21">1008704</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d317a841-a32f-4c3a-94ab-97da9f30c57b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">360530</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ca83c872-ac6e-4cc3-8b78-d8321a259ac1">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-10"></transaction-date>
   <value currency="USD" value-date="2021-04-10">341955</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Central Board of &#x2018;Aisyiyah</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="76826d7c-fae6-4e8c-b6f9-c324352ba337">
   <transaction-type code="7"></transaction-type>
   <transaction-date iso-date="2019-01-08"></transaction-date>
   <value currency="USD" value-date="2019-01-08">-746.15</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cc9e85d7-80a0-43e0-b9d5-c0d5213ed358">
   <transaction-type code="7"></transaction-type>
   <transaction-date iso-date="2019-01-22"></transaction-date>
   <value currency="USD" value-date="2019-01-22">-158.85</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IDN-T-AISYIYA.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://docs.theglobalfund.org/program-documents/GF_PD_002_e01d5429-d7f6-4b66-90e3-212b56e204d3.pdf">
   <title>
    <narrative xml:lang="EN">IDN-T-AISYIYA Program Agreement 4</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">IDN-T-AISYIYA Program Agreement 4</narrative>
   </description>
   <category code="A02"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <category code="A06"></category>
   <category code="A09"></category>
   <language code="EN"></language>
   <document-date iso-date="2015-05-30"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://docs.theglobalfund.org/program-documents/GF_PD_002_9cdd8c86-10fa-4fd4-8acc-7c7a8c069bc5.pdf">
   <title>
    <narrative xml:lang="EN">IDN-T-AISYIYA Program Agreement</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">IDN-T-AISYIYA Program Agreement</narrative>
   </description>
   <category code="A02"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <category code="A06"></category>
   <category code="A09"></category>
   <language code="EN"></language>
   <document-date iso-date="2016-08-10"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://docs.theglobalfund.org/program-documents/GF_PD_003_e8a4b67c-fd2c-4cac-b5a5-24439898dd78.pdf">
   <title>
    <narrative xml:lang="EN">IDN-T-AISYIYA Grant Performance Report</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">IDN-T-AISYIYA Grant Performance Report</narrative>
   </description>
   <category code="A01"></category>
   <category code="A02"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <category code="A06"></category>
   <category code="A07"></category>
   <category code="A08"></category>
   <language code="EN"></language>
   <document-date iso-date="2015-12-10"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://docs.theglobalfund.org/program-documents/GF_PD_003_9d22ee0e-425b-430b-acba-e84dedf24fc7.pdf">
   <title>
    <narrative xml:lang="EN">IDN-T-AISYIYA Grant Performance Report</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">IDN-T-AISYIYA Grant Performance Report</narrative>
   </description>
   <category code="A01"></category>
   <category code="A02"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <category code="A06"></category>
   <category code="A07"></category>
   <category code="A08"></category>
   <language code="EN"></language>
   <document-date iso-date="2016-12-06"></document-date>
  </document-link>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for IDN-T-AISYIYA</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">DOTS-other 1: Number of suspected TB cases referred by trained community cadres</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Numerator: 46271</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">MDR TB-other 1: Number of MDR-TB patients supported by CSO for adherence to treatment and default tracing in selected sites</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Numerator: 50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB/HIV-other 3: Number and percentage of TB patients with known HIV status - TB patients registered during the reporting period who had an HIV test result recorded in the TB register among the total number of TB patients referred by the community cadres</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Numerator: 584 Denominator: 8707 Percentage: 6.70</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Numerator: 8707 Denominator: 108745 Percentage: 8.00</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for IDN-T-AISYIYA</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB cases with RR-TB and/or MDR-TB</narrative>
    </title>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 1.9</narrative>
     </comment>
    </baseline>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 2.8%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1.9</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1.9</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 2.80</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 2.80</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 2.80</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB/HIV mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 10</narrative>
     </comment>
    </baseline>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 3.1</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3.1</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3.1</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 9</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 9</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 8</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 40</narrative>
     </comment>
    </baseline>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 42</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 37</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 34</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 31</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 28</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 25</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 395</narrative>
     </comment>
    </baseline>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 403</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 383</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 368</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 364</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 344</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 319</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB prevalence rate per 100,000 population</narrative>
    </title>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 660</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 575</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 515</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for IDN-T-AISYIYA</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Text: 127</narrative>
     </comment>
    </baseline>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 139</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 202</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 225</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 240</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases - Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB&#x20F0; as a proportion of the estimated number of RR-TB and/or MDR-TB cases among notified TB cases</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Text: 25%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 50.00</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 59.00</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 36%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 534737 Denominator: 964533.1 Percentage: 55.44</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 602473 Denominator: 922058.8 Percentage: 65.34</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 650602 Denominator: 864701.7 Percentage: 75.24</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2012">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Text: 47%</narrative>
     </comment>
    </baseline>
    <baseline year="2012">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Text: 51%</narrative>
     </comment>
    </baseline>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Text: 51%</narrative>
     </comment>
    </baseline>
    <baseline year="2012">
     <comment>
      <narrative xml:lang="EN">Text: 54%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 65.00</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 70.00</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 233 Denominator: 388.4 Percentage: 59.99</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 349 Denominator: 537.282 Percentage: 64.96</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 745 Denominator: 1146.6 Percentage: 64.97</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 85%</narrative>
     </comment>
    </baseline>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 88%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 141</narrative>
       <narrative xml:lang="EN">Target for: 2016</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 157</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 353706 Denominator: 393006 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 481263 Denominator: 534737 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 542226 Denominator: 602473.2 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="EN">Text: 9%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 6745 Denominator: 30260 Percentage: 22.29</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 10408 Denominator: 28927 Percentage: 35.98</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 14526 Denominator: 27128 Percentage: 53.55</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB O-Other 1: Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated using shorter regimen</narrative>
    </title>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3440 Denominator: 4586.4 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 5620 Denominator: 7493.6 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
